Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Hepatitis C prevalence in injecting drug users in Europe, 1990-2007: impact of study recruitment setting

M. Rondy, L. Wiessing, SJ. Hutchinson, C. Matheï, F. Mathis, V. Mravcik, L. Norden, M. Rosińska, O. Scutelniciuc, B. Suligoi, F. Vallejo, M. VAN Veen, M. Kretzschmar,

. 2013 ; 141 (3) : 563-72.

Language English Country England, Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc14064267

Monitoring injecting drug users' (IDUs) health is challenging because IDUs form a difficult to reach population. We examined the impact of recruitment setting on hepatitis C prevalence. Individual datasets from 12 studies were merged. Predictors of HCV positivity were sought through a multilevel analysis using a mixed-effects logistic model, with study identifier as random intercept. HCV prevalence ranged from 21% to 86% across the studies. Overall, HCV prevalence was higher in IDUs recruited in drug treatment centres compared to those recruited in low-threshold settings (74% and 42%, respectively, P < 0·001). Recruitment setting remained significantly associated with HCV prevalence after adjustment for duration of injecting and recent injection (adjusted odds ratio 0·7, 95% confidence interval 0·6-0·8, P = 0·05). Recruitment setting may have an impact on HCV prevalence estimates of IDUs in Europe. Assessing the impact of mixed recruitment strategies, including respondent-driven sampling, on HCV prevalence estimates, would be valuable.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc14064267
003      
CZ-PrNML
005      
20140709115005.0
007      
ta
008      
140704s2013 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1017/S0950268812000921 $2 doi
035    __
$a (PubMed)22595549
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Rondy, M $u Centre for Infectious Disease Control, National Institute for Public Health and the Environment, The Netherlands.
245    10
$a Hepatitis C prevalence in injecting drug users in Europe, 1990-2007: impact of study recruitment setting / $c M. Rondy, L. Wiessing, SJ. Hutchinson, C. Matheï, F. Mathis, V. Mravcik, L. Norden, M. Rosińska, O. Scutelniciuc, B. Suligoi, F. Vallejo, M. VAN Veen, M. Kretzschmar,
520    9_
$a Monitoring injecting drug users' (IDUs) health is challenging because IDUs form a difficult to reach population. We examined the impact of recruitment setting on hepatitis C prevalence. Individual datasets from 12 studies were merged. Predictors of HCV positivity were sought through a multilevel analysis using a mixed-effects logistic model, with study identifier as random intercept. HCV prevalence ranged from 21% to 86% across the studies. Overall, HCV prevalence was higher in IDUs recruited in drug treatment centres compared to those recruited in low-threshold settings (74% and 42%, respectively, P < 0·001). Recruitment setting remained significantly associated with HCV prevalence after adjustment for duration of injecting and recent injection (adjusted odds ratio 0·7, 95% confidence interval 0·6-0·8, P = 0·05). Recruitment setting may have an impact on HCV prevalence estimates of IDUs in Europe. Assessing the impact of mixed recruitment strategies, including respondent-driven sampling, on HCV prevalence estimates, would be valuable.
650    _2
$a dospělí $7 D000328
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a hepatitida C $x epidemiologie $7 D006526
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    12
$a programy výměny jehel a stříkaček $7 D018671
650    12
$a výběr pacientů $7 D018579
650    _2
$a prevalence $7 D015995
650    _2
$a výzkumný projekt $7 D012107
650    _2
$a výběrový bias $7 D015983
650    _2
$a séroepidemiologické studie $7 D016036
650    12
$a centra pro terapii drogových závislostí $7 D016320
650    _2
$a intravenózní abúzus drog $x epidemiologie $7 D015819
651    _2
$a Evropa $x epidemiologie $7 D005060
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Wiessing, L $u European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Portugal.
700    1_
$a Hutchinson, S J $u Health Protection Scotland, Glasgow, UK.
700    1_
$a Matheï, C $u Academic Centre of General Practice, Katholieke Universiteit Leuven, Belgium.
700    1_
$a Mathis, F $u ASL TO3 - Piedmont Centre for Drug Addiction Epidemiology (OED), Italy.
700    1_
$a Mravcik, V $u National Monitoring Centre for Drugs and Drug Addiction, Czech Republic.
700    1_
$a Norden, L $u Karolinska Institutet, Sweden.
700    1_
$a Rosińska, M $u National Institute of Public Health - National Institute of Hygiene, Warsaw, Poland.
700    1_
$a Scutelniciuc, O $u National Centre of Health Management, Republic of Moldova.
700    1_
$a Suligoi, B $u Istituto Superiore di Sanità, Italy.
700    1_
$a Vallejo, F $u Instituto de Salud Carlos III, Spain.
700    1_
$a VAN Veen, M $u Centre for Infectious Disease Control, National Institute for Public Health and the Environment, The Netherlands.
700    1_
$a Kretzschmar, M $u Centre for Infectious Disease Control, National Institute for Public Health and the Environment, The Netherlands.
773    0_
$w MED00001566 $t Epidemiology and infection $x 1469-4409 $g Roč. 141, č. 3 (2013), s. 563-72
856    41
$u https://pubmed.ncbi.nlm.nih.gov/22595549 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20140704 $b ABA008
991    __
$a 20140709115257 $b ABA008
999    __
$a ok $b bmc $g 1031751 $s 862999
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2013 $b 141 $c 3 $d 563-72 $i 1469-4409 $m Epidemiology and infection $n Epidemiol Infect $x MED00001566
LZP    __
$a Pubmed-20140704

Find record

Citation metrics

Archiving options